Focuses on producing actinium-225, a rare radioisotope used in targeted alpha therapies for cancer.
About
PanTera is a Belgian company focused on the large-scale, reliable production of Actinium-225 (Ac-225), a scarce radioisotope critical for emerging targeted alpha therapies in cancer treatment. They are constructing a state-of-the-art production facility in Mol, Belgium, utilizing a proprietary process to transform Radium-226 into high-purity Ac-225.
Tags
Total Employees
58
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does PanTera do?
PanTera is a Belgian company focused on the large-scale, reliable production of Actinium-225 (Ac-225), a scarce radioisotope critical for emerging targeted alpha therapies in cancer treatment. They are constructing a state-of-the-art production facility in Mol, Belgium, utilizing a proprietary process to transform Radium-226 into high-purity Ac-225.
How much funding has PanTera raised?
PanTera has raised a total of $122M in funding. The most recent round on record is Series A.
Where is PanTera headquartered?
PanTera is headquartered in Mol, Belgium.
When was PanTera founded?
PanTera was founded in 2022.
How many employees does PanTera have?
PanTera has approximately 58 people on record.